Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic effects of histone deacetylase inhibitors on kidney disease
Pusoon Chun
Archives of Pharmacal Research (2017) Vol. 41, Iss. 2, pp. 162-183
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
Himavanth R. Gatla, Nethaji Muniraj, Prashanth Thevkar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1110-1110
Open Access | Times Cited: 82
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors
Wenjie Li, Yiming Fu, Wei Wang
Annals of Hematology (2024) Vol. 103, Iss. 8, pp. 3207-3217
Closed Access | Times Cited: 12
Histone Deacetylase Inhibitors and Diabetic Kidney Disease
Mitchell J. Hadden, Andrew Advani
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2630-2630
Open Access | Times Cited: 71
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
José Luis Morgado‐Pascual, Vanessa Marchant, Raúl R. Rodrigues-Díez, et al.
Mediators of Inflammation (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 64
Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis
Fang Chen, Qi Gao, Wei Ai, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 3, pp. 1001-1012
Open Access | Times Cited: 60
Therapeutic effects of histone deacetylase inhibitors on heart disease
Pusoon Chun
Archives of Pharmacal Research (2020) Vol. 43, Iss. 12, pp. 1276-1296
Closed Access | Times Cited: 53
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler, Desirée Wünsch, Matthias Wirth, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 2, pp. 343-356
Open Access | Times Cited: 44
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Yuxiang Luo, Huilin Li
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8828-8828
Open Access | Times Cited: 39
The Role of HDACs and HDACi in Cartilage and Osteoarthritis
He Zhang, Lü Ji, Yue Yang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 33
Bibliometric visualization analysis of gut-kidney axis from 2003 to 2022
Sinan Ai, Yake Li, JiaYin Tao, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Renal ciliopathies
Laura A. Devlin, Rebecca Marie Dewhurst, Praveen Dhondurao Sudhindar, et al.
Current topics in developmental biology/Current Topics in Developmental Biology (2025)
Closed Access
Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation
Kelly A. Hyndman, Małgorzata Kasztan, Luciano D. Mendoza, et al.
AJP Renal Physiology (2019) Vol. 316, Iss. 5, pp. F875-F888
Open Access | Times Cited: 28
HDAC inhibitors rescue multiple disease-causing CFTR variants
Frédéric Anglès, Darren M. Hutt, William E. Balch
Human Molecular Genetics (2019) Vol. 28, Iss. 12, pp. 1982-2000
Open Access | Times Cited: 27
The roles of histone deacetylases in kidney development and disease
Hongbing Liu
Clinical and Experimental Nephrology (2021) Vol. 25, Iss. 3, pp. 215-223
Open Access | Times Cited: 23
Epigenetic modifications of Klotho expression in kidney diseases
Jinkun Xia, Wangsen Cao
Journal of Molecular Medicine (2021) Vol. 99, Iss. 5, pp. 581-592
Closed Access | Times Cited: 22
Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury
Keith Long, Zoe Vaughn, Michael D. McDaniels, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 4, pp. 207-215
Open Access | Times Cited: 15
Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients
Wanmeng Cui, Wenqi Luo, Xiaohui Zhou, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 24
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
Ling Nie, Yong Liu, Bo Zhang, et al.
Kidney Diseases (2020) Vol. 6, Iss. 4, pp. 226-235
Open Access | Times Cited: 21
Discovery and Development of HDAC Inhibitors: Approaches for the Treatment of Cancer a Mini-review
Roshani R. Patel, Arjun Modi, Hitesh Vekariya
Current Drug Discovery Technologies (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 2
Diabetic Nephropathy: Pathogenesis to Cure
Jeena Gupta, Kriti Kushwaha, Uma D. Kabra, et al.
Current Drug Targets (2022) Vol. 23, Iss. 15, pp. 1418-1429
Closed Access | Times Cited: 11
Renal ciliopathies: promising drug targets and prospects for clinical trials
Laura A. Devlin, Praveen Dhondurao Sudhindar, John A. Sayer
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 4-5, pp. 325-346
Open Access | Times Cited: 6
Histone deacetylases and inhibitors in diabetes mellitus and its complications
Wang Li, Yuning Bai, Zhengmin Cao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117010-117010
Open Access | Times Cited: 2
The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets
Jin-shu Pang, Zhe‐Kun Li, Peng Lin, et al.
Oncology Reports (2019)
Open Access | Times Cited: 19
HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB3
Shiyao Bai, Meng-Lu Li, Yuan Ren, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 71, pp. 102096-102096
Closed Access | Times Cited: 15
Molecular Mechanisms of Renal Progenitor Regulation: How Many Pieces in the Puzzle?
Anna Julie Peired, Maria Elena Melica, Alice Molli, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 59-59
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top